Table 1. Comparison of Patient- and Clinician-Reported Outcome Measure Scores Assessing Disease Severity Among Patients With Psoriasis.
DLQI score for disease severity | No. of patients (%) (N = 1733) | |||||
---|---|---|---|---|---|---|
PASI score for disease severity | BSA for disease severity | |||||
Mild (<3) | Moderate (3-9) | Severe (≥10) | Mild (<3%) | Moderate (3%-10%) | Severe (>11%) | |
Mild (<6) (n = 1201) | 621 (35.8) | 461 (26.6) | 119 (6.9) | 700 (40.4) | 353 (20.4) | 148 (8.5) |
Moderate (6-10) (n = 293) | 73 (4.2) | 149 (8.6) | 71 (4.1) | 79 (4.6) | 135 (7.8) | 79 (4.6) |
Severe (>10) (n = 239) | 39 (2.3) | 120 (6.9) | 80 (4.6) | 51 (2.9) | 104 (6.0) | 84 (4.9) |
Abbreviations: BSA, body surface area; DLQI, Dermatology Life Quality Index; PASI, Psoriasis Area Severity Index.